Pharmaceuticals Trio Draw Buy Ratings Ahead of 2026 Catalysts
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Frequent budget adjustments help you respond to income shifts and spending surprises. This intro guides quick, practical tweaks for staying on track.
26,559 articlesA trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
HPE reports a landmark shift in its earnings mix, with networking revenue over half of profits amid the Juniper Netwo...
Jim Cramer spotlights a surprising quarter from Marvell, arguing the company’s data center-focused growth could redef...
A quiet realignment in stablecoins is underway as Circle's USDC closes the gap with Tether's USDT, signaling a shift ...
A leading analyst warns of multi-year shortages coming optical as AI data-center growth strains suppliers. LUMENTUM a...
A Hong Kong-based stablecoin payments processor plans a $150 million pre-IPO round to fuel a possible U.S. listing th...
XRP continues to slide in March 2026 despite regulatory wins and Brazil expansion, with traders weighing macro risks,...
A Fidelity Investments report released in early 2026 highlights a growing willingness among Americans to mix work wit...
A California federal court weighs a landmark supply-chain risk dispute between Anthropic and the Department of War, w...
A high-profile Tampa real estate group is back with eXp Realty, rebranding as FIG Team Maximum Tampa and expanding it...
A growing chorus warns that AI-driven efficiency could trigger widespread job cuts. Coinbase’s leadership has amplifi...
Three ETFs tracking emerging markets ex China surge in 2026, underscoring a clear rotation away from China as investo...